NO158417C - Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer. - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer.

Info

Publication number
NO158417C
NO158417C NO830238A NO830238A NO158417C NO 158417 C NO158417 C NO 158417C NO 830238 A NO830238 A NO 830238A NO 830238 A NO830238 A NO 830238A NO 158417 C NO158417 C NO 158417C
Authority
NO
Norway
Prior art keywords
urinents
tiour
ingredients
preparation
pharmacologically active
Prior art date
Application number
NO830238A
Other languages
English (en)
Other versions
NO158417B (no
NO830238L (no
Inventor
Vern Gordon Devries
Elwood Eugene Largis
Ransom Brown Conrow
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/342,698 external-priority patent/US4387105A/en
Priority claimed from US06/342,693 external-priority patent/US4473579A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO830238L publication Critical patent/NO830238L/no
Publication of NO158417B publication Critical patent/NO158417B/no
Publication of NO158417C publication Critical patent/NO158417C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • C07C273/1809—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety
    • C07C273/1818—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety from -N=C=O and XNR'R"
    • C07C273/1827—X being H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO830238A 1982-01-26 1983-01-25 Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer. NO158417C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/342,698 US4387105A (en) 1982-01-26 1982-01-26 Methods of treating atherosclerosis with dialkylureas and dialkylthioureas
US06/342,693 US4473579A (en) 1982-01-26 1982-01-26 Antiatherosclerotic tetrasubstituted ureas and thioureas

Publications (3)

Publication Number Publication Date
NO830238L NO830238L (no) 1983-07-27
NO158417B NO158417B (no) 1988-05-30
NO158417C true NO158417C (no) 1988-09-07

Family

ID=26993144

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830238A NO158417C (no) 1982-01-26 1983-01-25 Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer.

Country Status (20)

Country Link
KR (1) KR890001808B1 (no)
AT (1) AT391313B (no)
AU (1) AU562699B2 (no)
CH (1) CH654571A5 (no)
DE (1) DE3247581A1 (no)
DK (1) DK160869C (no)
ES (2) ES519246A0 (no)
FI (1) FI85013C (no)
FR (1) FR2521134B1 (no)
GB (1) GB2113684B (no)
GR (1) GR77186B (no)
HU (1) HU200746B (no)
IE (1) IE54683B1 (no)
IL (1) IL67417A (no)
IT (1) IT1203647B (no)
NL (1) NL8300269A (no)
NO (1) NO158417C (no)
PL (1) PL143836B1 (no)
PT (1) PT76138A (no)
SE (1) SE462653B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2138804A (en) * 1983-04-27 1984-10-31 Sumitomo Chemical Co Fungicidal N-phenylcarbamates
GB2149394B (en) * 1983-07-19 1986-09-24 American Cyanamid Co Ureas
US4818899A (en) * 1986-12-03 1989-04-04 Minnesota Mining And Manufacturing Company Second harmonic generation by carbamic acid derivatives
US5116848A (en) * 1988-03-30 1992-05-26 Warner-Lambert Company N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
ATE98223T1 (de) * 1988-03-30 1993-12-15 Warner Lambert Co N-(((2,6-disubstituierte)phenyl>n'- arylalkyl> harnstoffe als antihypercholesterolemische und antiatherosclerotische mittel.
CA2076012A1 (en) * 1990-02-14 1991-08-15 Yasuyuki Kato Agent for inhibiting the formation of denatured ldl
US5668136A (en) * 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
HUT62558A (en) * 1991-07-01 1993-05-28 Sandoz Ag Process for producing n-phenylthiourea derivaties and pharmaceutical compositions comprising same
EP0609457B1 (en) * 1992-07-20 1997-10-29 Eisai Co., Ltd. Benzene derivative
WO1999007672A1 (en) * 1997-08-05 1999-02-18 Novo Nordisk A/S Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use
TW415942B (en) * 1997-09-03 2000-12-21 American Home Prod Novel substituted 1-aryl-3-heteroaryl-thioureas and substituted 1-aryl-3-heteroaryl-isothioureas as antiatherosclerotic agents
US6455566B1 (en) 1997-09-03 2002-09-24 Wyeth Substituted 1-aryl-3-heteroaryl-thioureas (or isothioureas) as antiatherosclerotic agents
US6221913B1 (en) * 1998-01-21 2001-04-24 Zymogenetics, Inc. Dialkyl ureas as calcitonin mimetics
JP5504484B2 (ja) * 2007-07-10 2014-05-28 アムジエン・インコーポレーテツド ウレア誘導体および関連ジアミン、これらの製造方法および使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL212631A (no) * 1949-12-06
US2688039A (en) * 1952-02-08 1954-08-31 Ciba Pharm Prod Inc Halogen-containing di-(substituted phenyl)-thioureas
US3326663A (en) * 1964-09-25 1967-06-20 Shell Oil Co Herbicidal phenylureas
US3335142A (en) * 1965-07-07 1967-08-08 American Cyanamid Co Process for the preparation of n, n'-disubstituted ureas
US3659012A (en) * 1969-05-26 1972-04-25 Lilly Co Eli Methods of treating helminth infections with thiourea derivatives
US3728386A (en) * 1970-07-27 1973-04-17 Exxon Research Engineering Co N-cycloalkylalkyl and n-cycloalkyl substituted phenyl ureas and halo acetamides
US3928437A (en) * 1970-09-02 1975-12-23 Ciba Geigy Corp Phenoxy-phenyl, phenylthiophenyl, phenylsulfonylphenyl and phenylaminophenyl diaminothioureas
US3856952A (en) * 1973-03-01 1974-12-24 Pennwalt Corp Synergistic antimicrobial compositions employing certain n-(phenyl-carbamyl)amino-benzene sulfonyl flourides
US3903130A (en) * 1974-05-03 1975-09-02 Stauffer Chemical Co 1-Trifluormethylphenyl-3-dicyanophenyl urea
DE2928485A1 (de) * 1979-07-14 1981-01-29 Bayer Ag Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen

Also Published As

Publication number Publication date
CH654571A5 (de) 1986-02-28
GR77186B (no) 1984-09-11
AU562699B2 (en) 1987-06-18
FI830247A0 (fi) 1983-01-25
DK28683D0 (da) 1983-01-25
DE3247581A1 (de) 1983-08-04
KR890001808B1 (ko) 1989-05-23
IT8347605A0 (it) 1983-01-25
GB2113684B (en) 1985-12-18
NO158417B (no) 1988-05-30
PL240284A1 (en) 1985-01-02
IE54683B1 (en) 1990-01-03
ES531508A0 (es) 1985-07-01
HU200746B (en) 1990-08-28
ES8505943A1 (es) 1985-07-01
FI830247L (fi) 1983-07-27
ES8406422A1 (es) 1984-08-01
SE8300370D0 (sv) 1983-01-25
IL67417A (en) 1989-10-31
AT391313B (de) 1990-09-25
FR2521134A1 (fr) 1983-08-12
IE830146L (en) 1983-07-26
DK28683A (da) 1983-07-27
FI85013C (fi) 1992-02-25
DK160869C (da) 1991-10-14
SE462653B (sv) 1990-08-06
DK160869B (da) 1991-04-29
AU1068183A (en) 1983-08-04
SE8300370L (sv) 1983-07-27
ATA23983A (de) 1990-03-15
PT76138A (en) 1983-02-01
KR840002773A (ko) 1984-07-16
IT1203647B (it) 1989-02-15
FR2521134B1 (fr) 1987-01-09
GB2113684A (en) 1983-08-10
FI85013B (fi) 1991-11-15
GB8301863D0 (en) 1983-02-23
ES519246A0 (es) 1984-08-01
NO830238L (no) 1983-07-27
PL143836B1 (en) 1988-03-31
NL8300269A (nl) 1983-08-16

Similar Documents

Publication Publication Date Title
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO161002C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.
NO821645L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater
NO156785B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO160850C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(bicykliske heterocyklyl)-4-piperidinaminer.
NO162189C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.
NO157738C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazinoner og benzoksazolinoner.
NO812344L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive steroider.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO820583L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(indolyl-piperidino-alkyl)-benzimidazolon-derivater.
NO883750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO158417C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer.
NO158876C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO834729L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tio-cefalosporiner
NO167664C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO157618C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamid-inderivater.